

ClearPoint Neuro announces Q1 earnings, beating revenue estimates but missing earnings estimates. Company affirms full-year sales guidance.
You can purchase shares of ClearPoint Neuro (NASDAQ:CLPT) through any online brokerage.
Other companies in ClearPoint Neuro’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
ClearPoint Neuro has a consensus price target of $26.25.
The stock price for ClearPoint Neuro (NASDAQ: CLPT) is $9.15 last updated October 23, 2026 at 7:42 PM EDT.
There are no upcoming dividends for ClearPoint Neuro.
ClearPoint Neuro does not have any upcoming earnings scheduled.
There is no upcoming split for ClearPoint Neuro.
ClearPoint Neuro is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a...